FDA Drug Application (077101) for QUASENSE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number077101
Product Number001
FormTABLET;ORAL
Dosage0.03MG;0.15MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameQUASENSE
Active IngredientETHINYL ESTRADIOL; LEVONORGESTREL

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient LEVONORGESTREL58


Back to FDA Applications sponsored by WATSON LABS